Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Active Shortage

IMITREX

GLAXOSMITHKLINE INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of IMITREX in Canada?

Yes. IMITREX 5MG has an active shortage reported to Health Canada (last updated November 4, 2026).

Why is IMITREX not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will IMITREX be available again?

The manufacturer's estimated resolution date is November 20, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist — only products with a different form or route found
StatusActive Shortage
Same-ingredient products on file6 products · 0 same form & route
Expected resolution~8 days remaining (estimate)
Affected strength5MG
Report last updated2026-11-04
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

IMITREX DF - TAB 100MG

GLAXOSMITHKLINE INC

100MG · DIN 02212161

Different strengthDifferent dosage formDifferent routeNo current shortage

IMITREX

GLAXOSMITHKLINE INC

6MG · DIN 02212188

Different strengthDifferent dosage formDifferent routeNo current shortage

MYLAN-SUMATRIPTAN

MYLAN PHARMACEUTICALS ULC

25MG · DIN 02268906

Different strengthDifferent dosage formDifferent routeNo current shortage

TEVA-SUMATRIPTAN

TEVA CANADA LIMITED

100MG · DIN 02239367

Different strengthDifferent dosage formDifferent routeNo current shortage

TEVA-SUMATRIPTAN DF

TEVA CANADA LIMITED

50MG · DIN 02286823

Different strengthDifferent dosage formDifferent routeNo current shortage

PMS-SUMATRIPTAN

PHARMASCIENCE INC

25MG · DIN 02256428

Different strengthDifferent dosage formDifferent routeNo current shortage

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2026-11-20

~8 days remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02230418

Strength

5MG

Dosage Form

SPRAY

Route

NASAL

Active Ingredient

SUMATRIPTAN

Tier

Unrated

Last Updated

2026-11-04

Reason for Shortage

Disruption of the manufacture of the drug.

Past Reports for This Drug

IMITREX has 2 shortage/discontinuation reports on file — this is one of them.